Skip to content
healthcare.dev

LISRAYA

NDC 87211-030, brepocitinib, tablet, film coated, from Priovant Therapeutics, Inc..

Product NDC
87211-030
Status
Listed
Labeler
Priovant Therapeutics, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA220106
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/87211-030 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BREPOCITINIB TOSYLATE30 mg/1
Package NDCNDC-11Package
87211-030-30872110030301 BOTTLE in 1 CARTON (87211-030-30) / 30 TABLET, FILM COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5023a17b-e96a-67d4-e063-6394a90a14a7

Use it

Look up 87211-030 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/87211-030 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 87211-030. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.